General MedicationsINJECTIONGeneric
BUPIVACAINE HYDROCHLORIDE KIT
BUPIVACAINE HYDROCHLORIDE
Standard Dose
0.23%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview BUPIVACAINE HYDROCHLORIDE KIT is listed in Drugs@FDA under application 019978 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.23% Sponsor HOSPIRA Submission history Latest submission status date: 1999-01-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview BUPIVACAINE HYDROCHLORIDE KIT is listed in Drugs@FDA under application 019978 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.23% Sponsor HOSPIRA Submission history Latest submission status date: 1999-01-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.